Top Biotechnology & Medical Research stocks in Europe
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LONNLonza AG | CH₣37.47bn | 36.08 | 0.77% |
ARGXargenx SE | €21.31bn | n/a | n/a |
GMABGenmab A/S | DKK134.26bn | 24.89 | n/a |
BANBBACHEM HOLDING AG | CH₣6.02bn | 53.43 | 1% |
ZEALZealand Pharma A/S | DKK38.77bn | n/a | n/a |
MORMorphosys AG | €2.51bn | n/a | n/a |
BIONBB Biotech AG | CH₣2.31bn | 7.52 | 4.74% |
GLPGGalapagos NV | €1.78bn | 212.21 | n/a |
EVTEvotec SE | €1.73bn | n/a | n/a |
BIOA BBioArctic AB | SEK17.10bn | 74.73 | n/a |
GNSGenus | £1.23bn | 31.58 | 1.71% |
ALIF BAddLife AB | SEK12.43bn | 337.82 | 0.49% |
ABVXAbivax SA | €884.62m | n/a | n/a |
ERGOErgomed | £701.05m | 43.1 | n/a |
FYBFormycon AG | €762.78m | 6.53 | n/a |
PHILPhilogen SpA | €723.20m | n/a | n/a |
PRTCPuretech Health | £592.20m | n/a | n/a |
GUBRAGubra A/S | DKK4.89bn | n/a | n/a |
BSLNBasilea Pharmaceutica AG Allschwil | CH₣478.07m | 45.78 | n/a |
VLAValneva SE | €476.60m | n/a | n/a |